Lumeda is advancing PDT for treating lung cancer.  Lumeda boasts a multidisciplinary team with decades of experience in engineering design, product development, and commercialization of photonics products from the component to systems level.  The core PDT technology was pioneered and developed at Roswell Park Comprehensive Cancer Center, which today is a worldwide leader in applying PDT for treating numerous types of cancer.  Lumeda is working cooperatively with Gal Shafirstein PhD, Director of PDT Clinical Research at Roswell Park, and his team- the inventors of the IO-PDT innovation- in its refinement and subsequent commercialization. This powerful combination of PDT and photonics expertise is augmented by strong healthcare executive leadership and an advisory board of medical professionals who provide critical input on product design and introduction to the surgical oncology community.

Our Team

Alexander (Sandy) Zinke
Chief Executive Officer

Sandy Zinke joined Lumeda as Chief Executive Officer to lead the company in its product commercialization and growth phase.  A graduate of Harvard Business School (MBA), Mr. Zinke has over 20 years of global healthcare industry experience with innovative companies including Boston Scientific, Cynosure / Hologic and CDx Diagnostics.  Most recently, he was Vice President of Marketing & Business Development with CDx Diagnostics, known for an advanced diagnostic platform used to preemptively detect cancer based on AI-enabled tissue analysis and 3D imaging.  Over the last 10 years he has led teams that have developed and commercialized more than a dozen products and programs.  Sandy has a strong track record of success in building and leading cross-functional teams to drive global growth of healthcare companies with innovative medical device and diagnostics products. He brings to Lumeda significant domain expertise and a network of industry contacts to develop key relationships with medical thought leaders and commercial partners critical to accelerate the introduction of the company’s novel PDT technology to the clinic.

Trevor MacDougall
Founder & VP of Engineering


Leads technical, engineering, and operations at Lumeda.  Over 30 years experience in the design and commercialization of fiber optic components and sensing systems.  Co-founder of QOREX with successful exit via acquisition in 2012. Senior technical positions at Weatherford, CiDRA Corporation, and 3M.  BS/MSEE; 55 patents and 20 publications in the field of fiber optics.  Co-author of Fiber Optic Sensors: Fundamentals and Applications 4th Edition (SPIE 2015). Member Institute of Electrical and Electronic Engineers (IEEE).

Paul E. Sanders
Founder & VP of Business Development


Leads business development and strategic partnering activities at Lumeda. Over 35-years photonics industry experience in technical, product management and business development roles.  Successful track record in the development and commercialization of optical components and sensing system products with industry leaders such as 3M, JDSU, CiDRA Corporation, and Weatherford.  Co-founder of QOREX with successful exit via acquisition in 2012.  BS Chemistry; 38 issued patents and 40 published technical papers and trade articles; team member of R&D 100 Award (1991 and 1992) and Photonics Circle of Excellence Award (1992 and 1996); Member Optical Society of America (OSA).

Scientific Advisory Board

Justin D. Blasberg MD, MPH, FACS
Associate Professor of Surgery (Thoracic Surgery)
Director of Robotic Thoracic Surgery
Yale School of Medicine
Smilow Cancer Hospital Thoracic Oncology Program

Dr. Blasberg is an Associate Professor of Surgery and Director of Robotic Thoracic Surgery at the Yale School of Medicine. He earned his medical degree from the Albert Einstein College of Medicine of Yeshiva University and completed his cardiothoracic training at the Massachusetts General Hospital. Dr Blasberg is a Board Certified General Surgeon (ACS) and a Board Certified Thoracic Surgeon (ABTS).  His practice includes minimally invasive and open management for diseases of the esophagus, lung, mediastinum, chest wall, thoracic outlet, and diaphragm. He has a particular interest in benign and malignant diseases of the trachea, including idiopathic laryngotracheal stenosis and post-intubation stenosis, as well as complex lung resections requiring bronchoplasty. He also performs first rib resection and anterior scalenectomy for all varieties of thoracic outlet syndrome, sympathectomy for hyperhidrosis, and minimally invasive chest wall reconstructions for pectus deformities. As a skilled surgeon, Dr. Blasberg performs the majority of his surgeries, when possible, in a minimally invasive fashion. Dr. Blasberg has a vision and a passion for Medicine, Surgery, and improving the care of the patient. He best embodies the young academic surgeon possessing an inquisitive mind, perseverant work ethic, and an engaging personality. Dr. Blasberg leads a clinical research program on novel imaging techniques for the detection of lung cancer and surgical outcomes research in thoracic surgery.

Michael M. Conway MD
Board Certification American Board of Internal Medicine
Board Certification Pulmonary Disease

Dr. Conway is a Pulmonary Disease and Internal Medicine specialist who practiced in Hartford, Connecticut. He graduated from Cornell University in 1968 and the University of California, San Francisco Medical School in 1973. He completed his residency at the University of Colorado, Denver in 1976 and his Pulmonary Fellowship at the University of Connecticut in 1978. Dr. Conway has 40+ years of diverse experience in Pulmonary Disease. He has been affiliated with Hartford Hospital where he was Active Senior Staff in the Pulmonary Division and held several administrative appointments there including President of the Medical Staff, Chief of the Pulmonary Division, and a Director of Patient Care Information Systems.  He was an Associate Professor, University of Connecticut Health Center (Farmington) School of Medicine and Consultant in Pulmonary Disease at Connecticut Children’s Medical Center in Hartford.  He is a Connecticut Thoracic Society Honoree and frequently named among Best Doctors in Hartford and Best Doctors in Connecticut.  A recognized pulmonary expert with strong regional ties, Dr. Conway brings to Lumeda significant knowledge and expertise in diagnosing and staging of respiratory cancers and associated standards of care and treatment options.

Gal Shafirstein DSc, MSc, BSc
Member & Professor of Oncology
Director of Photodynamic Therapy Clinical Research
Photodynamic Therapy Center
Department of Cell Stress Biology
Roswell Park Comprehensive Cancer Center

Dr. Shafirstein leads photodynamic therapy (PDT) translational and clinical research at Roswell Park Comprehensive Cancer Center. His laboratory research work focuses on treatment planning and light dosimetry for interstitial and intraoperative PDT, with the aim to improve the quality of life and survival for patients with locally advanced head neck cancer or lung cancer, who failed to respond to standard therapies or have no effective current treatments. This work performed in close collaboration with physicians to translate the technologies developed in the laboratory into the clinic. The laboratory supports clinical studies and off label use of PDT in the treatment of patients with head and neck and lung cancer. He is a principal investigator or project leader on 4 NIH awards. He designed and secured funding for multiple clinical studies in PDT, with two currently active.  He is the co-inventor of 8 issued patents, co-authored  79 peer reviewed scientific papers, frequent invited speaker. Honors and Awards include 2002 Lyon New Scientist Development Award, Arkansas Children’s Hospital, 1986-1992 Technion, Presidential Scholarship for excellence in studies, 1988 Shenkar Prize for distinction in research and studies, University award, 1987-1988 Distinction in the academic year, 1988 Gutwirth Prize for distinction in studies, University award, and 1989 National Award, Landau Prize for distinction in research. Section Editor, Engineering/Physics, International Journal of Hyperthermia. Fellow, American Society for Laser Medicine and Surgery (ASLMS), Member International Photodynamic Association, Associate Member American Head and Neck Society.



Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit


Cycle Venture Partners is a Connecticut based, early stage venture capital firm committed to supporting proven entrepreneurs and management teams to build innovative and industry leading businesses in the medical and biotechnology sectors.